Industry Research Reports
Home > Reports > Medical Care > Zika Virus Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Zika Virus Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Medical Care
Published Date: 2026-01-04
Pages: 112 Pages
Report ld: 5500281
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Zika Virus Testing Market Size(US$)
CAGR 2026-2032
3.1%
Market Size,2032
USD 156
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 130 million
Market Forecast in 2032(Value)
US$ 156 million
CAGR
3.1%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Zika Virus Testing was estimated to be worth US$ 127 million in 2025 and is projected to reach US$ 156 million, growing at a CAGR of 3.1% from 2026 to 2032.
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
Global Zika Virus Testing key players include Chembio, Quest Diagnostics, ARUP Laboratories, Luminex Corporation, Simens, etc. Global top five manufacturers hold a share about 55%. North America is the largest market, with a share about 45%, followed by Europe, with a share about 30 percent. In terms of product, Molecular Test is the largest segment, with a share about 90%. And in terms of application, the largest application is Diagnostic Centers, followed by Hospitals, Pathology Labs, etc.
This report provides a comprehensive view of the global market for Zika Virus Testing, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Zika Virus Testing market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Zika Virus Testing.
MARKET SEGMENTATION
By Company
- Chembio
- Quest Diagnostics
- ARUP Laboratories
- Luminex
- Simens
- Abbott Molecular
- Hologic
- ELITech Molecular Diagnostics
- EUROIMMUN US
- Creative Diagnostics
- Vela Diagnostics
- InBios International
- Primerdesign
- Altona Diagnostics
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Molecular Test
- Serologic Test
Segment by Application
- Diagnostic Centers
- Hospitals
- Pathology Labs
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Zika Virus Testing companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Zika Virus Testing revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Zika Virus Testing revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Zika Virus Testing Product Introduction
1.2 Global Zika Virus Testing Market Size Forecast (2021–2032)
1.3 Zika Virus Testing Market Trends & Drivers
1.3.1 Zika Virus Testing Industry Trends
1.3.2 Zika Virus Testing Market Drivers & Opportunities
1.3.3 Zika Virus Testing Market Challenges
1.3.4 Zika Virus Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Zika Virus Testing Players Revenue Ranking (2025)
2.2 Global Zika Virus Testing Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies Zika Virus Testing Product Offerings
2.5 Key Companies General Availability (GA) Timeline for Zika Virus Testing
2.6 Zika Virus Testing Market Competitive Analysis
2.6.1 Zika Virus Testing Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by Zika Virus Testing Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Zika Virus Testing revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation Zika Virus Testing Market Classification
3.1 Introduction by Type
3.1.1 Molecular Test
3.1.2 Serologic Test
3.1.3 Global Zika Virus Testing Sales Value by Type
3.1.3.1 Global Zika Virus Testing Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Zika Virus Testing Sales Value, by Type (2021–2032)
3.1.3.3 Global Zika Virus Testing Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Diagnostic Centers
4.1.2 Hospitals
4.1.3 Pathology Labs
4.2 Global Zika Virus Testing Sales Value by Application
4.2.1 Global Zika Virus Testing Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Zika Virus Testing Sales Value by Application (2021–2032)
4.2.3 Global Zika Virus Testing Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global Zika Virus Testing Sales Value by Region
5.1.1 Global Zika Virus Testing Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Zika Virus Testing Sales Value by Region (2021–2026)
5.1.3 Global Zika Virus Testing Sales Value by Region (2027–2032)
5.1.4 Global Zika Virus Testing Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America Zika Virus Testing Sales Value, 2021–2032
5.2.2 North America Zika Virus Testing Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe Zika Virus Testing Sales Value, 2021–2032
5.3.2 Europe Zika Virus Testing Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific Zika Virus Testing Sales Value, 2021–2032
5.4.2 Asia Pacific Zika Virus Testing Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America Zika Virus Testing Sales Value, 2021–2032
5.5.2 South America Zika Virus Testing Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa Zika Virus Testing Sales Value, 2021–2032
5.6.2 Middle East & Africa Zika Virus Testing Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Zika Virus Testing Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Zika Virus Testing Sales Value, 2021–2032
6.3 United States
6.3.1 United States Zika Virus Testing Sales Value, 2021–2032
6.3.2 United States Zika Virus Testing Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Zika Virus Testing Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Zika Virus Testing Sales Value, 2021–2032
6.4.2 Europe Zika Virus Testing Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Zika Virus Testing Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Zika Virus Testing Sales Value, 2021–2032
6.5.2 China Zika Virus Testing Sales Value by Type (%), 2025 vs 2032
6.5.3 China Zika Virus Testing Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Zika Virus Testing Sales Value, 2021–2032
6.6.2 Japan Zika Virus Testing Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Zika Virus Testing Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Zika Virus Testing Sales Value, 2021–2032
6.7.2 South Korea Zika Virus Testing Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Zika Virus Testing Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Zika Virus Testing Sales Value, 2021–2032
6.8.2 Southeast Asia Zika Virus Testing Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Zika Virus Testing Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Zika Virus Testing Sales Value, 2021–2032
6.9.2 India Zika Virus Testing Sales Value by Type (%), 2025 vs 2032
6.9.3 India Zika Virus Testing Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Chembio
7.1.1 Chembio Profile
7.1.2 Chembio Main Business
7.1.3 Chembio Zika Virus Testing Products, Services, and Solutions
7.1.4 Chembio Zika Virus Testing Revenue (US$ Million), 2021–2026
7.1.5 Chembio Recent Developments
7.2 Quest Diagnostics
7.2.1 Quest Diagnostics Profile
7.2.2 Quest Diagnostics Main Business
7.2.3 Quest Diagnostics Zika Virus Testing Products, Services, and Solutions
7.2.4 Quest Diagnostics Zika Virus Testing Revenue (US$ Million), 2021–2026
7.2.5 Quest Diagnostics Recent Developments
7.3 ARUP Laboratories
7.3.1 ARUP Laboratories Profile
7.3.2 ARUP Laboratories Main Business
7.3.3 ARUP Laboratories Zika Virus Testing Products, Services, and Solutions
7.3.4 ARUP Laboratories Zika Virus Testing Revenue (US$ Million), 2021–2026
7.3.5 ARUP Laboratories Recent Developments
7.4 Luminex
7.4.1 Luminex Profile
7.4.2 Luminex Main Business
7.4.3 Luminex Zika Virus Testing Products, Services, and Solutions
7.4.4 Luminex Zika Virus Testing Revenue (US$ Million), 2021–2026
7.4.5 Luminex Recent Developments
7.5 Simens
7.5.1 Simens Profile
7.5.2 Simens Main Business
7.5.3 Simens Zika Virus Testing Products, Services, and Solutions
7.5.4 Simens Zika Virus Testing Revenue (US$ Million), 2021–2026
7.5.5 Simens Recent Developments
7.6 Abbott Molecular
7.6.1 Abbott Molecular Profile
7.6.2 Abbott Molecular Main Business
7.6.3 Abbott Molecular Zika Virus Testing Products, Services, and Solutions
7.6.4 Abbott Molecular Zika Virus Testing Revenue (US$ Million), 2021–2026
7.6.5 Abbott Molecular Recent Developments
7.7 Hologic
7.7.1 Hologic Profile
7.7.2 Hologic Main Business
7.7.3 Hologic Zika Virus Testing Products, Services, and Solutions
7.7.4 Hologic Zika Virus Testing Revenue (US$ Million), 2021–2026
7.7.5 Hologic Recent Developments
7.8 ELITech Molecular Diagnostics
7.8.1 ELITech Molecular Diagnostics Profile
7.8.2 ELITech Molecular Diagnostics Main Business
7.8.3 ELITech Molecular Diagnostics Zika Virus Testing Products, Services, and Solutions
7.8.4 ELITech Molecular Diagnostics Zika Virus Testing Revenue (US$ Million), 2021–2026
7.8.5 ELITech Molecular Diagnostics Recent Developments
7.9 EUROIMMUN US
7.9.1 EUROIMMUN US Profile
7.9.2 EUROIMMUN US Main Business
7.9.3 EUROIMMUN US Zika Virus Testing Products, Services, and Solutions
7.9.4 EUROIMMUN US Zika Virus Testing Revenue (US$ Million), 2021–2026
7.9.5 EUROIMMUN US Recent Developments
7.10 Creative Diagnostics
7.10.1 Creative Diagnostics Profile
7.10.2 Creative Diagnostics Main Business
7.10.3 Creative Diagnostics Zika Virus Testing Products, Services, and Solutions
7.10.4 Creative Diagnostics Zika Virus Testing Revenue (US$ Million), 2021–2026
7.10.5 Creative Diagnostics Recent Developments
7.11 Vela Diagnostics
7.11.1 Vela Diagnostics Profile
7.11.2 Vela Diagnostics Main Business
7.11.3 Vela Diagnostics Zika Virus Testing Products, Services, and Solutions
7.11.4 Vela Diagnostics Zika Virus Testing Revenue (US$ Million), 2021–2026
7.11.5 Vela Diagnostics Recent Developments
7.12 InBios International
7.12.1 InBios International Profile
7.12.2 InBios International Main Business
7.12.3 InBios International Zika Virus Testing Products, Services, and Solutions
7.12.4 InBios International Zika Virus Testing Revenue (US$ Million), 2021–2026
7.12.5 InBios International Recent Developments
7.13 Primerdesign
7.13.1 Primerdesign Profile
7.13.2 Primerdesign Main Business
7.13.3 Primerdesign Zika Virus Testing Products, Services, and Solutions
7.13.4 Primerdesign Zika Virus Testing Revenue (US$ Million), 2021–2026
7.13.5 Primerdesign Recent Developments
7.14 Altona Diagnostics
7.14.1 Altona Diagnostics Profile
7.14.2 Altona Diagnostics Main Business
7.14.3 Altona Diagnostics Zika Virus Testing Products, Services, and Solutions
7.14.4 Altona Diagnostics Zika Virus Testing Revenue (US$ Million), 2021–2026
7.14.5 Altona Diagnostics Recent Developments
8 Industry Chain Analysis
8.1 Zika Virus Testing Value Chain
8.2 Zika Virus Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 Zika Virus Testing Sales Model
8.5.2 Sales Channels
8.5.3 Zika Virus Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Zika Virus Testing Market Trends
Table 2. Zika Virus Testing Market Drivers & Opportunities
Table 3. Zika Virus Testing Market Challenges
Table 4. Zika Virus Testing Market Restraints
Table 5. Global Zika Virus Testing Revenue by Company (US$ Million), 2021–2026
Table 6. Global Zika Virus Testing Revenue Market Share by Company (2021–2026)
Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
Table 8. Key Companies Zika Virus Testing Product Type
Table 9. Key Companies General Availability (GA) Timeline for Zika Virus Testing
Table 10. Global Zika Virus Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Zika Virus Testing revenue, 2025
Table 12. Mergers & Acquisitions and Expansion Plans
Table 13. Global Zika Virus Testing Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 14. Global Zika Virus Testing Sales Value by Type (US$ Million), 2021–2026
Table 15. Global Zika Virus Testing Sales Value by Type (US$ Million), 2027–2032
Table 16. Global Zika Virus Testing Sales Market Share in Value by Type (2021–2026)
Table 17. Global Zika Virus Testing Sales Market Share in Value by Type (2027–2032)
Table 18. Global Zika Virus Testing Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 19. Global Zika Virus Testing Sales Value by Application (US$ Million), 2021–2026
Table 20. Global Zika Virus Testing Sales Value by Application (US$ Million), 2027–2032
Table 21. Global Zika Virus Testing Sales Market Share in Value by Application (2021–2026)
Table 22. Global Zika Virus Testing Sales Market Share in Value by Application (2027–2032)
Table 23. Global Zika Virus Testing Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 24. Global Zika Virus Testing Sales Value by Region (US$ Million), 2021–2026
Table 25. Global Zika Virus Testing Sales Value by Region (US$ Million), 2027–2032
Table 26. Global Zika Virus Testing Sales Value by Region (%), 2021–2026
Table 27. Global Zika Virus Testing Sales Value by Region (%), 2027–2032
Table 28. Key Countries/Regions Zika Virus Testing Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 29. Key Countries/Regions Zika Virus Testing Sales Value, (US$ Million), 2021–2026
Table 30. Key Countries/Regions Zika Virus Testing Sales Value, (US$ Million), 2027–2032
Table 31. Chembio Basic Information List
Table 32. Chembio Description and Business Overview
Table 33. Chembio Zika Virus Testing Products, Services, and Solutions
Table 34. Revenue (US$ Million) in Zika Virus Testing Business of Chembio (2021–2026)
Table 35. Chembio Recent Developments
Table 36. Quest Diagnostics Basic Information List
Table 37. Quest Diagnostics Description and Business Overview
Table 38. Quest Diagnostics Zika Virus Testing Products, Services, and Solutions
Table 39. Revenue (US$ Million) in Zika Virus Testing Business of Quest Diagnostics (2021–2026)
Table 40. Quest Diagnostics Recent Developments
Table 41. ARUP Laboratories Basic Information List
Table 42. ARUP Laboratories Description and Business Overview
Table 43. ARUP Laboratories Zika Virus Testing Products, Services, and Solutions
Table 44. Revenue (US$ Million) in Zika Virus Testing Business of ARUP Laboratories (2021–2026)
Table 45. ARUP Laboratories Recent Developments
Table 46. Luminex Basic Information List
Table 47. Luminex Description and Business Overview
Table 48. Luminex Zika Virus Testing Products, Services, and Solutions
Table 49. Revenue (US$ Million) in Zika Virus Testing Business of Luminex (2021–2026)
Table 50. Luminex Recent Developments
Table 51. Simens Basic Information List
Table 52. Simens Description and Business Overview
Table 53. Simens Zika Virus Testing Products, Services, and Solutions
Table 54. Revenue (US$ Million) in Zika Virus Testing Business of Simens (2021–2026)
Table 55. Simens Recent Developments
Table 56. Abbott Molecular Basic Information List
Table 57. Abbott Molecular Description and Business Overview
Table 58. Abbott Molecular Zika Virus Testing Products, Services, and Solutions
Table 59. Revenue (US$ Million) in Zika Virus Testing Business of Abbott Molecular (2021–2026)
Table 60. Abbott Molecular Recent Developments
Table 61. Hologic Basic Information List
Table 62. Hologic Description and Business Overview
Table 63. Hologic Zika Virus Testing Products, Services, and Solutions
Table 64. Revenue (US$ Million) in Zika Virus Testing Business of Hologic (2021–2026)
Table 65. Hologic Recent Developments
Table 66. ELITech Molecular Diagnostics Basic Information List
Table 67. ELITech Molecular Diagnostics Description and Business Overview
Table 68. ELITech Molecular Diagnostics Zika Virus Testing Products, Services, and Solutions
Table 69. Revenue (US$ Million) in Zika Virus Testing Business of ELITech Molecular Diagnostics (2021–2026)
Table 70. ELITech Molecular Diagnostics Recent Developments
Table 71. EUROIMMUN US Basic Information List
Table 72. EUROIMMUN US Description and Business Overview
Table 73. EUROIMMUN US Zika Virus Testing Products, Services, and Solutions
Table 74. Revenue (US$ Million) in Zika Virus Testing Business of EUROIMMUN US (2021–2026)
Table 75. EUROIMMUN US Recent Developments
Table 76. Creative Diagnostics Basic Information List
Table 77. Creative Diagnostics Description and Business Overview
Table 78. Creative Diagnostics Zika Virus Testing Products, Services, and Solutions
Table 79. Revenue (US$ Million) in Zika Virus Testing Business of Creative Diagnostics (2021–2026)
Table 80. Creative Diagnostics Recent Developments
Table 81. Vela Diagnostics Basic Information List
Table 82. Vela Diagnostics Description and Business Overview
Table 83. Vela Diagnostics Zika Virus Testing Products, Services, and Solutions
Table 84. Revenue (US$ Million) in Zika Virus Testing Business of Vela Diagnostics (2021–2026)
Table 85. Vela Diagnostics Recent Developments
Table 86. InBios International Basic Information List
Table 87. InBios International Description and Business Overview
Table 88. InBios International Zika Virus Testing Products, Services, and Solutions
Table 89. Revenue (US$ Million) in Zika Virus Testing Business of InBios International (2021–2026)
Table 90. InBios International Recent Developments
Table 91. Primerdesign Basic Information List
Table 92. Primerdesign Description and Business Overview
Table 93. Primerdesign Zika Virus Testing Products, Services, and Solutions
Table 94. Revenue (US$ Million) in Zika Virus Testing Business of Primerdesign (2021–2026)
Table 95. Primerdesign Recent Developments
Table 96. Altona Diagnostics Basic Information List
Table 97. Altona Diagnostics Description and Business Overview
Table 98. Altona Diagnostics Zika Virus Testing Products, Services, and Solutions
Table 99. Revenue (US$ Million) in Zika Virus Testing Business of Altona Diagnostics (2021–2026)
Table 100. Altona Diagnostics Recent Developments
Table 101. Revenue (US$ Million) in Zika Virus Testing Business of Company 40 (2021–2026)
Table 102. Company 40 Recent Developments
Table 103. Key Raw Materials Lists
Table 104. Key Suppliers of Raw Materials Lists
Table 105. Zika Virus Testing Downstream Customers
Table 106. Zika Virus Testing Distributors List
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Zika Virus Testing Product Picture
Figure 2. Global Zika Virus Testing Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Zika Virus Testing Sales Value (US$ Million), 2021–2032
Figure 4. Zika Virus Testing Report Years Considered
Figure 5. Global Zika Virus Testing Players Revenue Ranking (US$ Million), 2025
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Zika Virus Testing Revenue in 2025
Figure 7. Zika Virus Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 8. Molecular Test Picture
Figure 9. Serologic Test Picture
Figure 10. Global Zika Virus Testing Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Zika Virus Testing Sales Value Market Share by Type, 2025 & 2032
Figure 12. Product Picture of Diagnostic Centers
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Pathology Labs
Figure 15. Global Zika Virus Testing Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Zika Virus Testing Sales Value Market Share by Application, 2025 & 2032
Figure 17. North America Zika Virus Testing Sales Value (US$ Million), 2021–2032
Figure 18. North America Zika Virus Testing Sales Value by Country (%), 2025 vs 2032
Figure 19. Europe Zika Virus Testing Sales Value (US$ Million), 2021–2032
Figure 20. Europe Zika Virus Testing Sales Value by Country (%), 2025 vs 2032
Figure 21. Asia Pacific Zika Virus Testing Sales Value (US$ Million), 2021–2032
Figure 22. Asia Pacific Zika Virus Testing Sales Value by Subregion (%), 2025 vs 2032
Figure 23. South America Zika Virus Testing Sales Value (US$ Million), 2021–2032
Figure 24. South America Zika Virus Testing Sales Value by Country (%), 2025 vs 2032
Figure 25. Middle East & Africa Zika Virus Testing Sales Value (US$ Million), 2021–2032
Figure 26. Middle East & Africa Zika Virus Testing Sales Value by Country (%), 2025 vs 2032
Figure 27. Key Countries/Regions Zika Virus Testing Sales Value (%), 2021–2032
Figure 28. United States Zika Virus Testing Sales Value (US$ Million), 2021–2032
Figure 29. United States Zika Virus Testing Sales Value by Type (%), 2025 vs 2032
Figure 30. United States Zika Virus Testing Sales Value by Application (%), 2025 vs 2032
Figure 31. Europe Zika Virus Testing Sales Value (US$ Million), 2021–2032
Figure 32. Europe Zika Virus Testing Sales Value by Type (%), 2025 vs 2032
Figure 33. Europe Zika Virus Testing Sales Value by Application (%), 2025 vs 2032
Figure 34. China Zika Virus Testing Sales Value (US$ Million), 2021–2032
Figure 35. China Zika Virus Testing Sales Value by Type (%), 2025 vs 2032
Figure 36. China Zika Virus Testing Sales Value by Application (%), 2025 vs 2032
Figure 37. Japan Zika Virus Testing Sales Value (US$ Million), 2021–2032
Figure 38. Japan Zika Virus Testing Sales Value by Type (%), 2025 vs 2032
Figure 39. Japan Zika Virus Testing Sales Value by Application (%), 2025 vs 2032
Figure 40. South Korea Zika Virus Testing Sales Value (US$ Million), 2021–2032
Figure 41. South Korea Zika Virus Testing Sales Value by Type (%), 2025 vs 2032
Figure 42. South Korea Zika Virus Testing Sales Value by Application (%), 2025 vs 2032
Figure 43. Southeast Asia Zika Virus Testing Sales Value (US$ Million), 2021–2032
Figure 44. Southeast Asia Zika Virus Testing Sales Value by Type (%), 2025 vs 2032
Figure 45. Southeast Asia Zika Virus Testing Sales Value by Application (%), 2025 vs 2032
Figure 46. India Zika Virus Testing Sales Value (US$ Million), 2021–2032
Figure 47. India Zika Virus Testing Sales Value by Type (%), 2025 vs 2032
Figure 48. India Zika Virus Testing Sales Value by Application (%), 2025 vs 2032
Figure 49. Zika Virus Testing Value Chain
Figure 50. Zika Virus Testing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 3.1% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What is the annual compound growth rate of the global Zika Virus Testing market size from 2026 to 2032?
What was the global market size of Zika Virus Testing in 2032?
Which companies rank high in the global Zika Virus Testing market?
What was the global market size of Zika Virus Testing in 2026?
Related Reports
Global Zika Virus Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Zika Virus Testing market size was US$ 127 million in 2025 and is forecast to reach a readjusted size of US$ 156 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 92
USD 4250.00
(Single User License)
Global Zika Virus Testing Market Research Report 2026
The global Zika Virus Testing market was valued at US$ 127 million in 2025 and is anticipated to reach US$ 156 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 119
USD 2900.00
(Single User License)
Global Zika Virus Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Zika Virus Testing market is projected to grow from US$ 123 million in 2024 to US$ 152 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 131
USD 4900.00
(Single User License)
Global Zika Virus Testing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Zika Virus Testing was estimated to be worth US$ 123 million and is forecast to reach approximately US$ 152 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 144
USD 5900.00
(Single User License)
Global Zika Virus Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Zika Virus Testing market size was US$ 123 million in 2024 and is forecast to a readjusted size of US$ 152 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 92
USD 4250.00
(Single User License)
Zika Virus Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Zika Virus Testing was estimated to be worth US$ 123 million in 2024 and is forecast to a readjusted size of US$ 152 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 103
USD 3950.00
(Single User License)
Global Zika Virus Testing Market Research Report 2025
The global market for Zika Virus Testing was valued at US$ 123 million in the year 2024 and is projected to reach a revised size of US$ 152 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-01-16
Pages: 89
USD 2900.00
(Single User License)
Global Zika Virus Testing Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
Published Date: 2024-04-17
Pages: 153
USD 5600.00
(Single User License)
Global Zika Virus Testing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
Published Date: 2024-04-16
Pages: 156
USD 5900.00
(Single User License)
Global Zika Virus Testing Market Insights, Forecast to 2030
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
Published Date: 2024-04-07
Pages: 105
USD 4900.00
(Single User License)
Global Zika Virus Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Zika Virus Testing market size was US$ 127 million in 2025 and is forecast to reach a readjusted size of US$ 156 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 92
USD 4250.00 (Single User License)Global Zika Virus Testing Market Research Report 2026
The global Zika Virus Testing market was valued at US$ 127 million in 2025 and is anticipated to reach US$ 156 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 119
USD 2900.00 (Single User License)Global Zika Virus Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Zika Virus Testing market is projected to grow from US$ 123 million in 2024 to US$ 152 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 131
USD 4900.00 (Single User License)Global Zika Virus Testing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Zika Virus Testing was estimated to be worth US$ 123 million and is forecast to reach approximately US$ 152 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 144
USD 5900.00 (Single User License)Global Zika Virus Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Zika Virus Testing market size was US$ 123 million in 2024 and is forecast to a readjusted size of US$ 152 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 92
USD 4250.00 (Single User License)Zika Virus Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Zika Virus Testing was estimated to be worth US$ 123 million in 2024 and is forecast to a readjusted size of US$ 152 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 103
USD 3950.00 (Single User License)Global Zika Virus Testing Market Research Report 2025
The global market for Zika Virus Testing was valued at US$ 123 million in the year 2024 and is projected to reach a revised size of US$ 152 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-01-16
Pages: 89
USD 2900.00 (Single User License)Global Zika Virus Testing Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
Published: 2024-04-17
Pages: 153
USD 5600.00 (Single User License)Global Zika Virus Testing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
Published: 2024-04-16
Pages: 156
USD 5900.00 (Single User License)Global Zika Virus Testing Market Insights, Forecast to 2030
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
Published: 2024-04-07
Pages: 105
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now